Active Biotech AB

BTPC

Company Profile

  • Business description

    Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

  • Contact

    Scheelevagen 22
    P.O. Box 724
    Lund223 63
    SWE

    T: +46 46192000

    E: [email protected]

    https://www.activebiotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    5

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,777.9050.80-0.58%
CAC 407,871.36104.651.35%
DAX 4024,539.68332.771.37%
Dow JONES (US)44,440.82200.060.45%
FTSE 1008,864.9010.720.12%
HKSE23,892.32255.75-1.06%
NASDAQ20,607.60189.130.93%
Nikkei 22539,821.28132.470.33%
NZX 50 Index12,768.6190.41-0.70%
S&P 5006,261.7836.260.58%
S&P/ASX 2008,538.6052.10-0.61%
SSE Composite Index3,493.054.43-0.13%

Market Movers